BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 21970456)

  • 1. Cytotoxic function of umbilical cord blood natural killer cells: relevance to adoptive immunotherapy.
    Lin SJ; Kuo ML
    Pediatr Hematol Oncol; 2011 Nov; 28(8):640-6. PubMed ID: 21970456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
    Lin SJ; Kuo ML
    Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the alloreactive capacity of human umbilical cord blood: implications for graft-versus-host disease.
    Harris DT; LoCascio J; Besencon FJ
    Bone Marrow Transplant; 1994 Oct; 14(4):545-53. PubMed ID: 7858529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells.
    Boissel L; Tuncer HH; Betancur M; Wolfberg A; Klingemann H
    Biol Blood Marrow Transplant; 2008 Sep; 14(9):1031-1038. PubMed ID: 18721766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Umbilical cord blood transplantation--how, when and for whom?
    Cohen Y; Nagler A
    Blood Rev; 2004 Sep; 18(3):167-79. PubMed ID: 15183901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel method to expand large numbers of CD56(+) natural killer cells from a minute fraction of selectively accessed cryopreserved cord blood for immunotherapy after transplantation.
    Vasu S; Berg M; Davidson-Moncada J; Tian X; Cullis H; Childs RW
    Cytotherapy; 2015 Nov; 17(11):1582-93. PubMed ID: 26432560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy.
    Spanholtz J; Tordoir M; Eissens D; Preijers F; van der Meer A; Joosten I; Schaap N; de Witte TM; Dolstra H
    PLoS One; 2010 Feb; 5(2):e9221. PubMed ID: 20169160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of human IL-2-activated natural killer and T cells on graft-versus-host disease and graft-versus-leukemia in SCID mice bearing human leukemic cells.
    Xun CQ; Thompson JS; Jennings CD; Brown SA
    Transplantation; 1995 Oct; 60(8):821-7. PubMed ID: 7482742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of interleukin-15 and Flt3-ligand on natural killer cell expansion and activation: umbilical cord vs. adult peripheral blood mononuclear cells.
    Lin SJ; Yang MH; Chao HC; Kuo ML; Huang JL
    Pediatr Allergy Immunol; 2000 Aug; 11(3):168-74. PubMed ID: 10981526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children.
    Koehl U; Esser R; Zimmermann S; Tonn T; Kotchetkov R; Bartling T; Sörensen J; Grüttner HP; Bader P; Seifried E; Martin H; Lang P; Passweg JR; Klingebiel T; Schwabe D
    Klin Padiatr; 2005; 217(6):345-50. PubMed ID: 16307421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical applications of adoptive natural killer cell immunotherapy for cancer: current status and future prospects.
    Guo H; Qian X
    Onkologie; 2010; 33(7):389-95. PubMed ID: 20631487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the alloreactivity and anti-leukemia reactivity of cord blood mononuclear cells.
    Keever CA; Abu-Hajir M; Graf W; McFadden P; Prichard P; O'Brien J; Flomenberg N
    Bone Marrow Transplant; 1995 Mar; 15(3):407-19. PubMed ID: 7599566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of influenza A infection on umbilical cord blood natural killer function regulation with interleukin-15.
    Lin SJ; Cheng PJ; Lin TY; Lee PT; Hsiao HS; Kuo ML
    J Infect Dis; 2012 Mar; 205(5):745-56. PubMed ID: 22262794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cord blood transplantation: implications for graft vs. host disease and graft vs. leukemia.
    Harris DT
    Blood Cells; 1994; 20(2-3):560-4; discussion 564-5. PubMed ID: 7749121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow mesenchymal stem cells reduce the antitumor activity of cytokine-induced killer/natural killer cells in K562 NOD/SCID mice.
    Li Y; Qu YH; Wu YF; Wang XP; Wei J; Huang WG; Zhou DH; Fang J; Huang K; Huang SL
    Ann Hematol; 2011 Aug; 90(8):873-85. PubMed ID: 21234566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells.
    Verneris MR; Miller JS
    Br J Haematol; 2009 Oct; 147(2):185-91. PubMed ID: 19796267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multifactorial analysis of umbilical cord blood, adult bone marrow and mobilized peripheral blood progenitors using the improved ML-IC assay.
    Theunissen K; Verfaillie CM
    Exp Hematol; 2005 Feb; 33(2):165-72. PubMed ID: 15676210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.